Syquant Capital Sas Genfit S.A. Transaction History

Syquant Capital Sas

  • $141 Million
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 17, 2019
SELL
$14.92 - $19.94 $344,652 - $460,614
-23,100 Closed
0 $0
Q2 2019

Jul 05, 2019
SELL
$19.74 - $25.65 $4.81 Million - $6.25 Million
-243,700 Reduced 91.34%
23,100 $456,000
Q1 2019

Apr 12, 2019
BUY
$22.17 - $24.0 $5.91 Million - $6.4 Million
266,800 New
266,800 $6.4 Million

Others Institutions Holding GNFT

# of Institutions
9
Shares Held
209K
Call Options Held
0
Put Options Held
0
View Full List

About Genfit S.A.

GNFT Quotes by TradingView
  • Ticker GNFT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,815,500
  • Market Cap $226M
  • Description
  • Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...
More about GNFT
Track This Portfolio

Track Syquant Capital Sas Portfolio

Follow Syquant Capital Sas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syquant Capital Sas, based on Form 13F filings with the SEC.

News

Stay updated on Syquant Capital Sas with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email